Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell RNA-Seq from bone marrow Ewing patients

ABSTRACT: We report the application of single-molecule-based sequencing technology for high-throughput profiling of bone marrow Ewing patients

ORGANISM(S): Homo sapiens

PROVIDER: GSE130020 | GEO | 2020/02/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Single cell RNA-Seq of Ewing Sarcoma PDX data (PDX_C1)

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of 3 Ewing Sarcoma PDX (PDX-83, 84 and 111) with the Fluidigm C1 technology.

2020-02-14 | GSE130023 | GEO

Single cell RNA-Seq of Ewing Sarcoma PDX data (PDX_Chromium)

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of 5 Ewing Sarcoma PDX (PDX-184, 352, 856, 861 and 1058) with the 10X Genomics Chromium technology.

2020-02-14 | GSE130024 | GEO

Single cell RNA-Seq from bone marrow Ewing patients

Project description:Single cell RNA-Seq from bone marrow Ewing patients

| PRJNA533606 | ENA

RNA sequencing of LPS-stimulated bone marrow-derived macrophages pre-treated with MB-3 or DMSO

Project description:We report the application of RNA sequencing technology for high-throughput profiling in mouse bone marrow-derived macrophages pre-treated with MB-3(50μM) or DMSO, and stimulated with LPS(100ng/ml) for 4 hours. The goal of this study is to search differential gene in indicated groups. Through differential gene analysis, we can find out the specific mechanism of MB-3 inhibits LPS-induced pro-inflammatory gene transcription but promotes the expression of gene involved in NRF2 pathway and anti-oxidation acitivity.

2023-06-01 | GSE205238 | GEO

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Project description:RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients who have hematologic cancer.

| 2004880 | ecrin-mdr-crc

Genome-wide chip of PDGF-BB induced mesenchymal stem cell.

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of MSC.

2020-06-17 | GSE152578 | GEO

Next Generation Sequencing of polyA+ RNA of cultured neural stem/progenitor cells (NSC) from mouse neonatal forebrain [RNA-seq]

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of NSC transcriptome.

2019-03-07 | GSE90560 | GEO

Methylome sequencing of Burkholderia pseudomallei strains Bp33 and Bp35

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of DNA methylations in Burkholderia pseudomallei. SMRTbell™ sequencing

2014-09-15 | E-GEOD-55168 | biostudies-arrayexpress

Methylome sequencing of Burkholderia pseudomallei strains Bp33 and Bp35

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of DNA methylations in Burkholderia pseudomallei.

2014-09-15 | GSE55168 | GEO

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Project description:This phase II trial studies how well giving fludarabine phosphate, cyclophosphamide, tacrolimus, mycophenolate mofetil and total-body irradiation together with a donor bone marrow transplant works in treating patients with high-risk hematologic cancer. Giving low doses of chemotherapy, such as fludarabine phosphate and cyclophosphamide, and total-body irradiation before a donor bone marrow transplant helps stop the growth of cancer cells by stopping them from dividing or killing them. Giving cyclophosphamide after transplant may also stop the patient’s immune system from rejecting the donor’s bone marrow stem cells. The donated stem cells may replace the patient’s immune system cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body’s normal cells. Giving tacrolimus and mycophenolate mofetil after the transplant may stop this from happening

| 2008483 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data